Related Experiment Video
Updated: Jun 23, 2025
07:29
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
19.6K
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies.
Sravani Ramisetty1, Ayalur Raghu Subbalakshmi1, Siddhika Pareek1
1Department of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA.
Journal of Clinical Medicine
|June 19, 2024
Summary
Phenotypic plasticity allows cancer cells to adapt and evolve, contributing to treatment resistance. Understanding these non-genetic adaptations is key to developing new cancer therapies.
Area of Science:
- Cancer Biology
- Evolutionary Medicine
Background:
- Phenotypic plasticity enables cancer cells to adapt to environmental changes, conferring a survival advantage.
- Cancer cell phenotypic plasticity drives population heterogeneity, a significant challenge in cancer treatment.
- Plasticity influences cancer cell group behavior, impacting drug resistance through interactions within the tumor microenvironment.
Purpose of the Study:
- To explore the role of phenotypic plasticity in cancer evolution and treatment resistance.
- To advocate for a systems-level understanding of cancer cell adaptation mechanisms.
- To propose a team medicine approach for developing novel therapeutic strategies.
Main Methods:
- Review and synthesis of current research on phenotypic plasticity in cancer.
- Conceptual framework development for a team medicine approach.
- Analysis of the impact of phenotypic plasticity on cancer cell heterogeneity and drug resistance.
Main Results:
- Phenotypic plasticity is a crucial non-genetic factor in cancer adaptation and evolution.
- Plasticity contributes significantly to cancer cell heterogeneity and therapeutic challenges.
- Understanding plasticity mechanisms can reveal new targets for cancer therapeutics.
Conclusions:
- A comprehensive, team medicine-based approach is essential for deciphering cancer cell phenotypic plasticity.
- Targeting plasticity mechanisms offers a promising avenue for developing innovative cancer treatments.
- Further research into the systems-level understanding of phenotypic plasticity is critical for overcoming cancer drug resistance.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:18Cancer
48.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.3K